Cite
Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy.
MLA
Kesselring, Anouk, et al. “Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy.” Clinical Infectious Diseases, vol. 52, no. 12, June 2011, pp. 1458–65. EBSCOhost, https://doi.org/10.1093/cid/cir207.
APA
Kesselring, A., Gras, L., Smit, C., van Twillert, G., Verbon, A., de Wolf, F., Reiss, P., & Wit, F. (2011). Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy. Clinical Infectious Diseases, 52(12), 1458–1465. https://doi.org/10.1093/cid/cir207
Chicago
Kesselring, Anouk, Luuk Gras, Colette Smit, Gitte van Twillert, Annelies Verbon, Frank de Wolf, Peter Reiss, and Ferdinand Wit. 2011. “Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy.” Clinical Infectious Diseases 52 (12): 1458–65. doi:10.1093/cid/cir207.